Status:
COMPLETED
LAMP Detection of Malaria in PREGnancy (LAMPREG) Trial
Lead Sponsor:
University of Calgary
Collaborating Sponsors:
Jimma University
Amhara Public Health Institute, Ethiopia
Conditions:
Malaria
Pregnancy Malaria
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Objective: The aim of this study is to evaluate the impact of enhanced malaria cases detection using molecular testing (LAMP) on maternal and infant morbidity and mortality in a prospective study desi...
Detailed Description
Malaria in pregnancy often results in high degree of morbidity and mortality of the pregnant mother and the fetus. Early and accurate diagnosis of subclinical infections will be critical to malaria el...
Eligibility Criteria
Inclusion
- Must be a pregnant woman in the first or second trimester at time of enrollment
- Consent to the study
Exclusion
- Pregnant woman in the third trimester at time of enrollment
- Multiparity
- Severe malaria at inclusion as per WHO criteria
- At risk pregnancy as per Ethiopian guidelines
- Impossibility to date pregnancy
Key Trial Info
Start Date :
June 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 20 2023
Estimated Enrollment :
2424 Patients enrolled
Trial Details
Trial ID
NCT03754322
Start Date
June 18 2021
End Date
November 20 2023
Last Update
December 4 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Calgary
Calgary, Alberta, Canada, T2L 2K8
2
Amhara Public Health Institute
Bahir Dar, Amhara, Ethiopia
3
Tropical & Infectious Diseases Research Center (TIDRC), Jimma University
Jimma, Oromiya, Ethiopia
4
Armauer Hansen Research Institute, Ethiopia
Addis Ababa, Ethiopia